Ionis Pharmaceuticals

Yahoo Finance • 23 days ago

Nature Medicine Publishes Results from the Pivotal DEVOTE Study of High-Dose Regimen of Nusinersen in Spinal Muscular Atrophy

Findings from DEVOTE support clinical benefits of the high-dose regimen of nusinersen (50 mg and 28 mg) in both treatment-naïve individuals and those previously treated with 12 mg nusinersenThe high-dose regimen of nusinersen also slowed n... Full story

Yahoo Finance • 24 days ago

Tweedy Browne's Strategic Moves: Significant Increase in CNH Industrial NV

This article first appeared on GuruFocus. Insight into Tweedy Browne (Trades, Portfolio)'s Fourth Quarter 2025 13F Filing Warning! GuruFocus has detected 5 Warning Sign with IONS. Is IONS fairly valued? Test your thesis with our free DCF... Full story

Yahoo Finance • 24 days ago

What a $20 Million Bet on a Stock Down 3% Signals for Investors

On February 2, Tweedy, Browne disclosed a new position in UniFirst(NYSE:UNF), acquiring 102,059 shares during the fourth quarter in an estimated $19.69 million trade based on quarterly average pricing. What happened According to a SEC fi... Full story

Yahoo Finance • 24 days ago

Autoliv Stock Is Up 32% in a Year, But One Fund Just Cut $3.8 Million

On February 2, Tweedy, Browne Co disclosed in an SEC filing that it sold 31,740 shares of Autoliv(NYSE:ALV), an estimated $3.79 million trade based on quarterly average pricing. What happened In an SEC filing dated February 2, Connecticu... Full story

Yahoo Finance • 2 months ago

Cathie Wood invests heavily in gene-editing companies, offloads $30 million worth Tesla stock

[Bitcoin 2022 Conference Draws Cryptocurrency Industry Professionals And Investors To Miami] Marco Bello Cathie Wood’s Ark Invest increased exposure to gene-editing names and autonomous mobility companies while further cutting holdings in... Full story

Yahoo Finance • 3 months ago

Ionis gets FDA breakthrough therapy status for zilganersen

[Neuron system disease] koto_feja/E+ via Getty Images * Ionis Pharmaceuticals (IONS [https://seekingalpha.com/symbol/IONS]) has received breakthrough therapy designation from the U.S. FDA for its drug zilganersen, aimed at treating Alex... Full story

Yahoo Finance • 3 months ago

Biogen Completes Acquisition of Alcyone Therapeutics

CAMBRIDGE, Mass., Nov. 14, 2025 (GLOBE NEWSWIRE) -- Biogen Inc. (Nasdaq: BIIB) has completed the acquisition of Alcyone Therapeutics, a clinical-stage biotechnology company known for its innovative CNS therapy delivery solutions, such a... Full story

Yahoo Finance • 3 months ago

Sanofi, Lilly among winners of EU drug recommendations this week

[Flag of European Union Waving Background] forest_strider/iStock via Getty Images During a meeting this week, an expert panel of the EU drug regulator, the European Medicines Agency (EMA), endorsed 10 new medicines for approval, including... Full story

Yahoo Finance • 3 months ago

Sector Update: Health Care Stocks Decline Premarket Friday

Health care stocks were declining premarket Friday, with the Health Care Select Sector SPDR Fund (XL PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premiu... Full story

Yahoo Finance • 4 months ago

Biggest stock movers Monday: RUM, MTSR, and more

[financial disaster and crisis protection when market price fall.] Wongsakorn Napaeng/iStock via Getty Images Stock futures edged up Monday morning as reports surfaced that Senate negotiators reached a stopgap agreement to end the longest... Full story

Yahoo Finance • 4 months ago

Ionis Unveils Positive Phase 3 Data For Olezarsen In Severe Hypertriglyceridemia

(RTTNews) - Ionis Pharmaceuticals Inc. (IONS) announced positive results from its pivotal Phase 3 CORE and CORE2 studies evaluating olezarsen in patients with severe hypertriglyceridemia (sHTG). The trials successfully met their primary en... Full story

Yahoo Finance • 4 months ago

Alnylam Stock Has Almost Doubled In 2025. But It Took A Hit On Earnings.

Alnylam stock took a hit Thursday after the biotech company said it received a subpoena from the U.S. government related to its four drugs. Continue Reading View Comments... Full story

Yahoo Finance • 4 months ago

Ionis raises 2025 revenue guidance to $900M as TRYNGOLZA and DAWNZERA launches accelerate

Earnings Call Insights: Ionis Pharmaceuticals (IONS) Q3 2025 MANAGEMENT VIEW * Brett Monia, CEO, stated the third quarter was a “watershed moment for Ionis as we made important progress advancing first and best-in-class medicines for s... Full story

Yahoo Finance • 4 months ago

Ionis CEO Brett P. Monia receives 2025 Lifetime Achievement Award from the Oligonucleotide Therapeutics Society

CARLSBAD, Calif., October 21, 2025--(BUSINESS WIRE)--Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today announced that Brett P. Monia, Ph.D., Ionis’ chief executive officer, was awarded the 2025 Lifetime Achievement Award from the Oligonucle... Full story

Yahoo Finance • 5 months ago

Stocks making the biggest moves midday: TopBuild, Confluent, Alcoa, Viasat, Joby Aviation and others

Check out the companies making the biggest moves midday: TopBuild — The insulation installer rallied almost 8% after agreeing to buy Specialty Products and Insulation for $1 billion in cash . "The addition of SPI's resources and capabiliti... Full story

Yahoo Finance • 5 months ago

Ionis upgraded at JP Morgan on expanding Tryngolza market, pipeline

[Wall Street sign with American flag in the background, symbolizing the financial heart of New York.] JP Morgan upgraded Ionis Pharmaceuticals (NASDAQ:IONS [https://seekingalpha.com/symbol/IONS]) to overweight from neutral citing a potent... Full story

Yahoo Finance • 5 months ago

Intel, FedEx downgraded: Wall Street's top analyst calls

The most talked about and market moving research calls around Wall Street are now in one place. Here are today's research calls that investors need to know, as compiled by The Fly. Top 5 Upgrades: Deutsche Bank upgraded Northrop Grumma... Full story

Yahoo Finance • 5 months ago

Stocks making the biggest moves premarket: AST SpaceMobile, Joby, Trilogy Metals, Rocket Lab and more

Check out the companies making headlines in premarket trading. Joby Aviation — Shares of the electric air taxi maker plunged 11% after the company announced the pricing of a previously announced stock offering. Joby will sell 30,500,000 co... Full story

Yahoo Finance • 5 months ago

Calumet, Inc. (CLMT): A Bull Case Theory

We came across a bullish thesis on Calumet, Inc. on The Pale Blue Dot’s Substack by Saad Khan. In this article, we will summarize the bulls’ thesis on CLMT. Calumet, Inc.'s share was trading at $18.66 as of September 22nd. CLMT’s trailing... Full story

Yahoo Finance • 5 months ago

CarMax downgraded, Kenvue upgraded: Wall Street's top analyst calls

The most talked about and market moving research calls around Wall Street are now in one place. Here are today's research calls that investors need to know, as compiled by The Fly. Top 5 Upgrades: Rothschild & Co Redburn upgraded Kenvue... Full story